Kenichi Sato

Dr. Kenichi Sato

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 1994 in Calcified Tissue International
Verified
Journal Article
Closed access
PDF file
YKY. Kaneko
Y. Kaneko
HTH. Tanzawa
H. Tanzawa
KSKenichi Sato
Kenichi Sato

1 August 1996 in Tetrahedron Letters
Verified
Journal Article
Closed access
Katsuhiko SuzukiKatsuhiko Suzuki
Katsuhiko Suzuki
TFTakashi Fujii
Takashi Fujii
KSKenichi Sato
Kenichi Sato
HHHironobu Hashimoto
Hironobu Hashimoto

28 October 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
YTYukichi Takada
Yukichi Takada
TSTatsuki Shibuta
Tatsuki Shibuta
MHMayu Hatano
Mayu Hatano
KSKenichi Sato
Kenichi Sato
MKMari Koga
Mari Koga
TUTsukuru Umemura
Tsukuru Umemura
Circulating microRNAs (miRNAs) are useful biomarkers of hemolysis. Since blood cells are the main origins of circulating miRNAs, we evaluated blood cell-related pre-analytical modification of the miRNA signatures during blood drawing and serum processing. The levels of miRNA before and after ex vivo blood drawing were analyzed with the reverse transcriptase-based polymerase chain reaction method. Furthermore, the changes of miRNA signatures caused by different time-lag between blood drawing and serum preparation by 24 h were evaluated. Finally, we compared the miRNA levels between leftover samples and samples of hemolytic diseases. Blood drawing procedure induced increments of red blood cell (RBC)-related miRNAs (miR-451a, miR-486) about 2-fold. One hour standing of blood samples before serum separation induced almost the same increases in RBC-related miRNAs. To test the clinical usefulness of miR-451a as a biomarker of hemolytic diseases, we analyzed miRNAs of samples from 10 normal subjects, 30 leftover samples in the clinical laboratory, and 20 samples from patients with hemolytic diseases. Serum miR-451a significantly increased in patients with hemolytic anemia more than the levels of pre-analytical modification. In conclusion, the pre-analytical modification of serum miRNAs did not disturb the usefulness of RBC-derived miRNAs as biomarkers of hemolytic diseases.

28 September 2014 in Clinical Biochemistry
Verified
Journal Article
Closed access
TITakayuki Ishige
Takayuki Ishige
SISakae Itoga
Sakae Itoga
KSKenichi Sato
Kenichi Sato
KKKouichi Kitamura
Kouichi Kitamura
MNMotoi Nishimura
Motoi Nishimura
FNFumio Nomura
Fumio Nomura